Ketoconazol Fiterman (Ketoconazole)

Ketoconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesising ergosterol, a key component of the fungal cell membrane. Inhibiting this pathway compromises membrane integrity, leading to fungal cell death or inhibited growth, thereby resolving the infection.

The specific dosage and frequency of Ketoconazol Fiterman are determined by the prescribing healthcare professional based on the infection type, severity, patient age and skin condition. Patients should follow the prescriber’s instructions and the product label carefully.

Safety data for topical ketoconazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoconazol belongs to the azole class, offering a broad spectrum against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, azoles have a different mechanism and may be preferred for conditions like seborrheic dermatitis where yeast overgrowth is prominent. Choice of therapy depends on infection type, patient factors and clinician judgment.

Ketoconazol Fiterman should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, direct sunlight and excessive heat to maintain product stability.

The cream or ointment is applied thinly to the affected skin area, usually twice daily, unless otherwise directed by a healthcare professional. Hands should be washed before and after application, and the treated area should be gently cleaned and dried prior to use.

Serious risks, though rare, include severe allergic reactions such as contact dermatitis, Stevens‑Johnson syndrome, and systemic toxicity from significant absorption leading to hepatic effects. Patients should discontinue use and seek immediate medical attention if they experience widespread rash, swelling, blistering or signs of liver dysfunction.

Individuals with a known hypersensitivity to ketoconazole, other azole antifungals, or any component of the formulation should avoid using the product. It is also contraindicated on extensive broken skin, mucous membranes and the ocular area.